Watch: Dr. Jamila Perritt on How Abortion Restrictions Worsen Maternal Health |
PRH President & CEO Dr. Jamila Perritt recently spoke on a panel hosted by The Century Foundation, a non-partisan think tank that focuses on research, solutions, and policy changes to make people’s lives better.
Alongside Congresswomen Ayanna Pressley and Jasmine Crockett, Brittany Mostiller from We Testify, and moderator Elizabeth Dawes, Dr. Perritt emphasized the deep connections between abortion access, maternal health, and reproductive justice, highlighting the need to safeguard bodily autonomy and address health disparities affecting marginalized communities.
|
|
|
With the Supreme Court back, If/When/How Reproductive Justice Fellow Natasha Rappazzo shares why we’ve got our eyes on U.S. v. Skrmetti. This is the first time the Court will hear arguments on whether transgender youth and their families can make their own medical decisions.
Oral arguments will be heard on December 4. Let us talk you through what’s at stake. |
|
|
On October 1, Louisiana officially criminalized mifepristone and misoprostol, life-saving medications that are critical to reproductive health care. PRH Fellow and Louisiana Ob/Gyn Dr. Neelima Sukhavasi spoke to Refinery29 about how this law will worsen already-high maternal mortality rates, delay urgent care, and instill fear in patients and providers. |
"Being pregnant, desiring pregnancy, and parenting your children does not absolve you from being at risk of criminalization." Dr. Jamila Perritt spoke with Salon about the increased surveillance and criminalization risk that pregnant people are facing post-Dobbs. |
Black women, who experience higher infertility rates than white patients, are more likely to face worse outcomes in IVF treatments because of systemic barriers to care. PRH Fellow Dr. Erinma Ukoha spoke with Rewire News Group about these obstacles, including harmful stigma, high costs, limited insurance coverage, and more. |
Watch: Changing the Narrative Around Miso-Only Medication Abortion Care |
The June Supreme Court decision to preserve access to mifepristone sparked broader conversations about medication abortion, highlighting that misoprostol-only protocols have long been integral to abortion care.
In response, PRH hosted a webinar earlier this month that brought together advocates and movement partners to discuss miso-only medication abortion focused on broadening our understanding, myth busting, and addressing stigma.
|
|
|
|
